- Home
- VERO vs SNOA Comparison
VERO vs SNOA Comparison
Compare VERO & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- SNOA
- Stock Information
- Founded
- VERO N/A
- SNOA 1999
- Country
- VERO Canada
- SNOA United States
- Employees
- VERO N/A
- SNOA N/A
- Industry
- VERO Medical/Dental Instruments
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- SNOA Health Care
- Exchange
- VERO Nasdaq
- SNOA Nasdaq
- Market Cap
- VERO 4.5M
- SNOA 6.4M
- IPO Year
- VERO N/A
- SNOA 2007
- Fundamental
- Price
- VERO $2.32
- SNOA $4.60
- Analyst Decision
- VERO
- SNOA
- Analyst Count
- VERO 0
- SNOA 0
- Target Price
- VERO N/A
- SNOA N/A
- AVG Volume (30 Days)
- VERO 44.0K
- SNOA 3.9M
- Earning Date
- VERO 08-14-2025
- SNOA 08-07-2025
- Dividend Yield
- VERO N/A
- SNOA N/A
- EPS Growth
- VERO N/A
- SNOA N/A
- EPS
- VERO N/A
- SNOA N/A
- Revenue
- VERO $60,107,000.00
- SNOA $14,912,000.00
- Revenue This Year
- VERO N/A
- SNOA $23.00
- Revenue Next Year
- VERO $7.47
- SNOA $24.59
- P/E Ratio
- VERO N/A
- SNOA N/A
- Revenue Growth
- VERO N/A
- SNOA 17.43
- 52 Week Low
- VERO $2.10
- SNOA $1.75
- 52 Week High
- VERO $14.50
- SNOA $6.92
- Technical
- Relative Strength Index (RSI)
- VERO 44.68
- SNOA 58.98
- Support Level
- VERO $2.34
- SNOA $4.54
- Resistance Level
- VERO $2.78
- SNOA $5.60
- Average True Range (ATR)
- VERO 0.14
- SNOA 0.47
- MACD
- VERO -0.00
- SNOA 0.01
- Stochastic Oscillator
- VERO 20.37
- SNOA 40.90
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.